# Accelerate Diagnostics (AXDX) Stock Price, News & Catalysts
Canonical URL: https://biopharmsignal.com/company/AXDX
## Company Profile
- Ticker: AXDX
- Exchange: NASDAQ
- Sector: MedTech
- Location: United States
- Tags: Diagnostics
## Stock Data
- Close: Not available
- Market cap: Not available
## Business Overview
Accelerate Diagnostics was a diagnostics company focused on rapid infectious-disease testing before its restructuring and decline. Its platform aimed to speed up bacterial identification and susceptibility testing.
## Why The Stock Is Moving

Current closing-price context is not available for AXDX.

## Geographic Base

Headquartered in the United States and listed on NASDAQ before restructuring, Accelerate sat in diagnostics and lab technology.

## Business Model

The company depended on test adoption, product execution, and the commercialization of rapid diagnostic workflows.

## Landscape Position

Accelerate is best viewed as a historical diagnostics and restructuring case rather than a live catalyst name.

## Future Catalysts

- Accelerate Diagnostics’ catalysts are platform utilization, turnaround execution, and whether the company can keep stabilizing its clinical-microbiology business. The stock is more about operational survival than one big catalyst.

## Recent News
- 2025-05-08 13:00 EST — [Accelerate Diagnostics Files for Chapter 11 Protection and Agrees to Terms to Sell Substantially All Assets](https://biopharmsignal.com/news/AXDX/accelerate-diagnostics-files-for-chapter-11-protection-and-agrees-to-terms-to-sell-substantially-all-assets) — Source: Accelerate Diagnostics
- 2025-03-21 17:52 EST — [Accelerate Diagnostics Submits WAVE System and Gram-Negative Positive Blood Culture Menu to the FDA for 510(k) Clearance](https://biopharmsignal.com/news/AXDX/accelerate-diagnostics-submits-wave-system-and-gram-negative-positive-blood-culture-menu-to-the-fda-for-510-k-clearance) — Source: Accelerate Diagnostics
- 2025-03-21 12:30 EST — [Accelerate Diagnostics Reports Fourth Quarter and Full-Year 2024 Financial Results](https://biopharmsignal.com/news/AXDX/accelerate-diagnostics-reports-fourth-quarter-and-full-year-2024-financial-results) — Source: Accelerate Diagnostics
- 2025-01-10 21:05 EST — [Accelerate Diagnostics Announces Certain Preliminary Fourth Quarter and Full-Year 2024 Results](https://biopharmsignal.com/news/AXDX/accelerate-diagnostics-announces-certain-preliminary-fourth-quarter-and-full-year-2024-results) — Source: Accelerate Diagnostics
- 2024-11-07 21:05 EST — [Accelerate Diagnostics Reports Third Quarter 2024 Financial Results](https://biopharmsignal.com/news/AXDX/accelerate-diagnostics-reports-third-quarter-2024-financial-results) — Source: Accelerate Diagnostics